(Q38421534)

2 September 2017

First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany (English)

1 reference

2 September 2017

0 references

12

Annemarie Berger

1 reference

2 September 2017

11

Hans Wilhelm Doerr

1 reference

2 September 2017

10

Holger F Rabenau

1 reference

2 September 2017

Michael Schmidt

1

1 reference

2 September 2017

Klaus Korn

2

1 reference

2 September 2017

C Micha Nübling

3

1 reference

2 September 2017

Michael Chudy

4

1 reference

2 September 2017

Julia Kress

5

1 reference

2 September 2017

Heinz A Horst

6

1 reference

2 September 2017

Geert Geusendam

7

1 reference

2 September 2017

Holger Hennig

8

1 reference

2 September 2017

Walid Sireis

9

1 reference

2 September 2017

Michael Kai Hourfar

13

1 reference

2 September 2017

Knut Gubbe

14

1 reference

2 September 2017

Andreas Karl

15

1 reference

2 September 2017

Helmut Fickenscher

16

1 reference

2 September 2017

B Karsten Tischer

17

1 reference

2 September 2017

Reiner Babiel

18

1 reference

2 September 2017

Erhard Seifried

19

1 reference

2 September 2017

Lutz Gürtler

20

1 reference

2 September 2017

11 May 2009

1 reference

2 September 2017

1 reference

2 September 2017

49

1 reference

2 September 2017

9

1 reference

2 September 2017

1836-1844

1 reference

Increase in prevalence of anti-HTLV-III in haemophiliacs

2 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

The German experience with NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Dynamics of viremia in early hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Emerging infectious diseases that threaten the blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Emerging viral diseases and infectious disease risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Surveillance of risk profiles among new and repeat blood donors with transfusion-transmissible infections from 1995 through 2003 in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

TaqMan 5'-nuclease human immunodeficiency virus type 1 PCR assay with phage-packaged competitive internal control for high-throughput blood donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

PROCLEIX West Nile virus assay based on transcription-mediated amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2009.02203.X

10.1111/J.1537-2995.2009.02203.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference